Table 1.

Current cancer immune therapies

Therapies	Indications (Trials)	Citations/Studies
Cytokine-based tumor vaccines	Hormone-naïve prostate cancer (Phase II)	10
Prophylactic vaccine and antiinflammatory therapies	HCC, Colorectal cancer	11–13
Cell-mediated vaccines	Metastatic melanoma, RCC (Phase II)	14, 15
Antigen-specific vaccines	Melanoma (Phase II), Ovarian carcinoma (Phase II)	16, 17
Monoclonal antibodies	Lymphoma, Leukemia	18, 19
Immune adjuvants	Metastatic melanoma (Phase II), Basal cell carcinoma (Phase I), Cutaneous T-cell lymphoma (Phase I)	20–23

RCC = renal cell carcinoma.